Explore more publications!
Healthcare Weekly Jamaica
Got News to Share?

Healthcare Weekly Jamaica: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Healthcare Weekly Jamaica.

November 2025

Mo Tu We Th Fr Sa Su
1 2
3 4 5 6 7 8 9
10 11 12 13 14 15 16
17 18 19 20 21 22 23
24 25 26 27 28 29 30

December 2025

Mo Tu We Th Fr Sa Su
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30 31

January 2026

Mo Tu We Th Fr Sa Su
1 2 3 4
5 6 7 8 9 10 11
12 13 14 15 16 17 18
19 20 21 22 23 24 25
26 27 28 29 30 31

Press releases published on January 21, 2026

BrainsWay Announces Draft Coverage Policy from Highmark® for Accelerated Deep TMS™
January 21, 2026

BrainsWay Announces Draft Coverage Policy from Highmark® for Accelerated Deep TMS™

Indeterminate GlobeNewswire
Venus Concept Announces Intention to Voluntary Delist from Nasdaq and Deregister with SEC
January 21, 2026

Venus Concept Announces Intention to Voluntary Delist from Nasdaq and Deregister with SEC

Indeterminate GlobeNewswire
Alterity Therapeutics Issues Shareholder Letter Highlighting 2025 Progress and Key Objectives for 2026
January 21, 2026

Alterity Therapeutics Issues Shareholder Letter Highlighting 2025 Progress and Key Objectives for 2026

Indeterminate GlobeNewswire
AnswersNow Completes $40M Series B to Expand BCBA-Driven, AI-Enabled Autism Therapy
January 21, 2026

AnswersNow Completes $40M Series B to Expand BCBA-Driven, AI-Enabled Autism Therapy

Indeterminate GlobeNewswire
Exicure to Present Data from Burixafor Phase 2 Trial at the 2026 Tandem Meetings
January 21, 2026

Exicure to Present Data from Burixafor Phase 2 Trial at the 2026 Tandem Meetings

Indeterminate GlobeNewswire
Ocular Therapeutix™ Appoints David W. Robinson as Global Chief Commercial Officer
January 21, 2026

Ocular Therapeutix™ Appoints David W. Robinson as Global Chief Commercial Officer

Indeterminate GlobeNewswire
Lisata Therapeutics Enters Into Term Sheet to be Acquired by Kuva Labs for $4.00 Per Share in an All-Cash Tender Offer
January 21, 2026

Lisata Therapeutics Enters Into Term Sheet to be Acquired by Kuva Labs for $4.00 Per Share in an All-Cash Tender Offer

Indeterminate GlobeNewswire
Skye Bioscience to Present Poster at Keystone Obesity Conference
January 21, 2026

Skye Bioscience to Present Poster at Keystone Obesity Conference

Indeterminate GlobeNewswire
Genmab Announces Net Sales of DARZALEX® (daratumumab) for 2025
January 21, 2026

Genmab Announces Net Sales of DARZALEX® (daratumumab) for 2025

Indeterminate GlobeNewswire
How Consumers Identify B-Complex Vitamins in 2026 Across Supplements, Gummies, and Liquid Formats: New Research from NUTRAHARMONY
January 21, 2026

How Consumers Identify B-Complex Vitamins in 2026 Across Supplements, Gummies, and Liquid Formats: New Research from NUTRAHARMONY

Indeterminate GlobeNewswire
Comphya Announces Publication of CaverSTIM First-in-Man Clinical Study in BJUI and Scientific Review in Nature Urology
January 21, 2026

Comphya Announces Publication of CaverSTIM First-in-Man Clinical Study in BJUI and Scientific Review in Nature Urology

Indeterminate GlobeNewswire
IO Biotech Announces Exploration of Strategic Alternatives
January 21, 2026

IO Biotech Announces Exploration of Strategic Alternatives

Indeterminate GlobeNewswire
Philips named a Clarivate Top 100 Global Innovator for the 13th consecutive year
January 21, 2026

Philips named a Clarivate Top 100 Global Innovator for the 13th consecutive year

Indeterminate GlobeNewswire
AMSilk’s bioengineered silk protein yarns debut in Balenciaga Spring 2026 Collection
January 21, 2026

AMSilk’s bioengineered silk protein yarns debut in Balenciaga Spring 2026 Collection

Indeterminate GlobeNewswire
Sergio Marullo di Condojanni nominato CEO di Angelini Pharma
January 21, 2026

Sergio Marullo di Condojanni nominato CEO di Angelini Pharma

Indeterminate GlobeNewswire
Angelini Pharma Announces Appointment of Sergio Marullo di Condojanni as New CEO
January 21, 2026

Angelini Pharma Announces Appointment of Sergio Marullo di Condojanni as New CEO

Indeterminate GlobeNewswire
Crucial Innovations Corp. Launches 4TP, a New Patient-Focused Brand of Cannabis-Based Products for Medicinal Use
January 21, 2026

Crucial Innovations Corp. Launches 4TP, a New Patient-Focused Brand of Cannabis-Based Products for Medicinal Use

Indeterminate GlobeNewswire
FDA Granted Hopstem’s hNPC01 for Chronic Ischemic Stroke Approval to Enter Phase 2/3 Adaptive Pivotal Clinical Trial with Bridging Study
January 21, 2026

FDA Granted Hopstem’s hNPC01 for Chronic Ischemic Stroke Approval to Enter Phase 2/3 Adaptive Pivotal Clinical Trial with Bridging Study

Indeterminate GlobeNewswire
Anteris Technologies Global Corp. Announces Pricing of $200 Million Public Offering
January 21, 2026

Anteris Technologies Global Corp. Announces Pricing of $200 Million Public Offering

Indeterminate GlobeNewswire

Share us

on your social networks:
Facebook Facebook LinkedIn LinkedIn
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions